Literature DB >> 7508045

Vascular renin-angiotensin system and vascular protection.

V J Dzau1.   

Abstract

Vascular angiotensin plays an important role in the long-term regulation of the blood vessel function and structure. Angiotensin stimulates vascular smooth-muscle cell growth via the induction of protooncogene and autocrine growth factor gene expressions. In hypertension, atherosclerosis and restenosis, vascular angiotensin activity is increased and participates in the pathobiology of these vascular diseases. Experimental data demonstrate that angiotensin-converting enzyme inhibitors can prevent vascular hypertrophy of hypertension, attenuate atherosclerosis, and inhibit neointimal hyperplasia of restenosis. Taken together, the data show that pharmacologic blockade of the vascular renin-angiotensin system may result in vascular protection. Ongoing clinical trials (MERCATOR, QUIET) will address the relevance of these experimental observations in clinical therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508045     DOI: 10.1097/00005344-199322005-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells.

Authors:  Ying Li; Dale A Kinzenbaw; Mary L Modrick; Lecia L Pewe; Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

2.  The vascular renin-angiotensin system contributes to blunted vasodilation induced by transient high pressure in human adipose microvessels.

Authors:  Matthew J Durand; Shane A Phillips; Michael E Widlansky; Mary F Otterson; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-01       Impact factor: 4.733

Review 3.  Microvascular angiogenesis and the renin-angiotensin system.

Authors:  Andrew S Greene; Sandra L Amaral
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

Review 4.  Diabetic vascular injury and ACE. Potential for pharmacological prevention of complications of later life.

Authors:  M E Cooper; D Vranes; J R Rumble
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

Review 5.  Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis.

Authors:  Matthias Barton
Journal:  Pflugers Arch       Date:  2010-07-16       Impact factor: 3.657

6.  Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.

Authors:  H Mitani; T Bandoh; J Ishikawa; M Kimura; T Totsuka; S Hayashi
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

7.  Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Authors:  Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Journal:  Exp Clin Cardiol       Date:  2007

Review 8.  Elastic properties and Windkessel function of the human aorta.

Authors:  G G Belz
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

9.  Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons.

Authors:  D Lu; H Yang; R H Lenox; M K Raizada
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.